Condition
Anti-Inflammatory Agents
Total Trials
6
Recruiting
1
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
P 1 (1)
P 2 (2)
P 3 (1)
P 4 (1)
Trial Status
Unknown2
Completed2
Recruiting1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05615948Phase 4Completed
Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression
NCT05611710Phase 2Active Not Recruiting
Anakinra in Dengue With Hyperinflammation ( AnaDen )
NCT06752018Recruiting
Inflammation's Impact on Heart Disease and Diabetes
NCT04377451Phase 1Completed
Metformin in Dengue With Obesity
NCT04743050Phase 3Unknown
The ALA, DHA and EPA Esters in the Prevention of Cardiovascular Diseases.
NCT03550781Phase 2Unknown
Anti-inflammatory Treatment for Inactive Takayasu Arteritis
Showing all 6 trials